|
1002
|
BCG AJV
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Live attenuated
|
AJ Vaccines
|
Approved
|
Intradermal
|
NA
|
NA
|
|
1211
|
Recombinant (dsc14CfaE-sCT2/LTB5)
|
E.coli Infections
|
Escherichia coli
|
Recombinant
|
U.S. Army Medical Research and Development Command
|
Clinical - Phase 1
|
Intradermal
|
NA
|
NCT01644565
|
|
1237
|
VPM1002
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Recombinant
|
Serum Institute of India Pvt. Ltd.
|
Clinical - Phase 2, Phase 3
|
Intradermal
|
NA
|
NCT03152903
|
|
1240
|
Immuvac
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Inactivated
|
Ministry of Science and Technology
|
Clinical - Phase 3
|
Intradermal
|
NA
|
NCT00265226
|